Evidence map›Paper›PMID 42795010›Full record

ArticleCancers2026

Clinical Significance of Tumor Infiltrating Lymphocytes and Modulation by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases.

Yasaman Rezaie, Kerryan Ashley, Janie Zhang, Thejal Srikumar, Jassim DiPalermo, Kurt A Schalper, Michael Cecchini

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yasaman RezaieDepartment of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.
Kerryan AshleyDepartment of Pathology, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.ORCID 0009-0006-4636-2201
Janie ZhangDepartment of Internal Medicine, University of Pittsburgh (UPMC), Pittsburgh, PA 15213, USA.ORCID 0000-0002-0459-2635
Thejal SrikumarDepartment of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.
Jassim DiPalermoDepartment of Pathology, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.
Kurt A SchalperDepartment of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.
Michael CecchiniDepartment of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT 06520, USA.

Funding

Understanding the role and clinical potential of dominant immune suppressive myeloid-cell responses in human cancerR01CA262377 · NCI · YALE UNIVERSITY · PI SCHALPER, KURT A · 2021 to 2025
$1.9M
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal CancerK08CA255465 · NCI · YALE UNIVERSITY · PI CECCHINI, MICHAEL · 2021 to 2025
$1.3M
NCI NIH HHS K08 CA255465NCI NIH HHS K08CA255465NCI NIH HHS R01 CA262377
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD8+ T-cellcolorectal cancer (CRC)colorectal cancer liver metastasis (CRCLM)immune microenvironmentneoadjuvant chemotherapyquantitative immunofluorescence (qIF)tissue infiltrating lymphocytes (TILs)

Identifiers

PMID42795010
PMCPMC13604633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.